Prelude Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-40,799
| Closed | -$2.4M | – | 1471 |
|
|
2023
Q4 | $2.4M | Buy |
40,799
+36,021
| +754% | +$2.12M | 0.16% | 126 |
|
|
2023
Q3 | $208K | Buy |
+4,778
| New | +$208K | 0.01% | 741 |
|
|
2020
Q4 | – | Sell |
-1,005
| Closed | -$167K | – | 1706 |
|
|
2020
Q3 | $167K | Buy |
+1,005
| New | +$167K | 0.01% | 549 |
|
|
2020
Q1 | – | Sell |
-121
| Closed | -$16K | – | 1691 |
|
|
2019
Q4 | $16K | Sell |
121
-2,872
| -96% | -$380K | ﹤0.01% | 1189 |
|
|
2019
Q3 | $233K | Buy |
+2,993
| New | +$233K | 0.01% | 418 |
|
|
2018
Q4 | – | Sell |
-2,951
| Closed | -$139K | – | 1823 |
|
|
2018
Q3 | $139K | Buy |
+2,951
| New | +$139K | 0.01% | 614 |
|
|
2016
Q4 | – | Sell |
-3,300
| Closed | -$22K | – | 1775 |
|
|
2016
Q3 | $22K | Buy |
+3,300
| New | +$22K | ﹤0.01% | 1259 |
|